RALEIGH, N.C. and OCEAN SPRINGS, Miss., May 23, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. (OTCBB:INOL), a service based healthcare products development, integration and marketing company, has announced a strategic joint venture with Gulf Coast Pharmaceuticals, Inc. for distribution and sales of its DNA-based products. Gulf Coast is a pharmaceutical supply company specializing in the nationwide distribution of pharmaceuticals and medical supplies to the healthcare industry.
